Access cutting-edge liver cancer treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access liver cancer specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver cancer treatment provided free
This Phase 1/ 2a study is a multicenter study to evaluate the safety, tolerability and efficacy of SCG101 in subjects with hepatitis B virus-related hepatocellular carcinoma
Sponsor: SCG Cell Therapy Pte. Ltd.
Check if you qualify for this liver cancer clinical trial in New York, NY
If you're searching for liver cancer treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.